Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MD Biomedical was a Taiwan-based medical device company focused on homecare and physiological monitoring products rather than therapeutics. Its commercial product portfolio included blood pressure ECG monitors, ECG pen devices, sleep screening systems, polysomnography-related technology, and positive airway pressure respiratory products such as OmniPAP. The company positioned itself around compact, lightweight, wearable and wireless diagnostic and monitoring devices for home and clinical use. Available corporate registry data indicates the company was dissolved in 2021, so it appears to be inactive today. It should be classified as a healthcare device and diagnostics company, not a biotech or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MD Biomedical.